Aprea Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aprea Therapeutics Inc
CIK #0001781983
EDGAR Form CIK 2011 - 2026
10-K [0001781983]
10-Q [0001781983]
3 [0001781983]
4 [0001781983]
8-K [0001781983]
D [0001781983]
SC 13D [0001781983]
SC 13G [0001781983]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP Aprea Therapeutics Inc [2026-05-15]
Squadron Capital Management LLC Aprea Therapeutics Inc [2026-04-07]
Soleus Private Equity Fund III LP Aprea Therapeutics Inc [2026-04-01]
Lytton Laurence W Aprea Therapeutics Inc [2025-11-17]
Nantahala Capital Management LLC Aprea Therapeutics Inc [2024-11-14]
Stonepine Capital Management LLC Aprea Therapeutics Inc [2024-10-10]
SIO Capital Management LLC Aprea Therapeutics Inc [2024-02-14]
Hirschman Orin Aprea Therapeutics Inc [2023-03-03]
Morgan Stanley Aprea Therapeutics Inc [2021-03-24]
KDEV Investments AB Aprea Therapeutics Inc [2020-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Henneman John B III
Aprea Therapeutics Inc
Pamukcu Rifat
Duey Marc
Grissinger Michael
Gruia Gabriela
Peters Richard
Bizzari Jean-Pierre
Seizinger Bernd R
Hamill John P
Gilad Oren
Mirza Nadeem Q
Korbel Gregory Alan
Schade Christian S
Coiante Scott M
Attar Eyal C
Abrahmsen Lars B
Namouni Fouad
Kelly Michael Aaron
Wessels Gregory S
Redmile Group LLC
Green Jeremy
5AM Opportunities I GP LLC
5AM Ventures IV LP
5AM Opportunities I LP
5AM Partners IV LLC
5AM Co-Investors IV LP
Schwab Andrew J
Parmar Kush
Diekman John D
Rocklage Scott M
Karolinska Development AB
KDev Investments AB
KCIF Co-Investment Fund KB
Christenson Johan
Hepple Jonathan
Versant Ventures V LLC
Versant Venture Capital V LP
Versant Affiliates Fund V LP
Versant Ventures V Canada LP
Versant Venture Capital V Canada LP
Versant Ophthalmic Affiliates I LP
Versant V Luxco Sa rl
Versant Vantage I LP
Versant Vantage I GP LP
Versant Vantage I GP-GP LLC
HealthCap VII LP
HealthCap VII GP SA
Magni Guido
Versant Ventures V GP-GP Canada Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
2026-03-12 Grant 40,380 $0.00
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
2026-03-12 Grant 80,700 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2026-03-12 Grant 10,095 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2026-03-12 Grant 20,175 $0.00
Aprea Therapeutics Inc APRE
Common Warrant · derivative
2026-01-30 Buy 5,700
Aprea Therapeutics Inc APRE
Common Warrant · derivative
2026-01-30 Buy 28,100
Aprea Therapeutics Inc APRE
Common Stock
2026-01-30 Buy 28,100 $0.89 25,009
Aprea Therapeutics Inc APRE
Common Stock
2026-01-30 Buy 5,700 $0.89 5,073
Aprea Therapeutics Inc APRE
Pre-Funded Warrant · derivative
2025-12-10 Buy 21,459 $1.17 25,107
Aprea Therapeutics Inc APRE
Common Stock
2025-12-10 Buy 21,459 $1.17 25,107
Aprea Therapeutics Inc APRE
Common Stock
2025-12-10 Buy 5,000 $1.17 5,850
Aprea Therapeutics Inc APRE
Common Warrant · derivative
2025-12-10 Buy 21,459
Aprea Therapeutics Inc APRE
Common Warrant · derivative
2025-12-10 Buy 5,000
Aprea Therapeutics Inc APRE
Common Warrants · derivative
2025-12-10 Buy 21,459
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
2025-06-05 Grant 4,185 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2025-06-05 Grant 1,045 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2025-06-05 Grant 1,045 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2025-06-05 Grant 1,045 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2025-06-05 Grant 1,045 $0.00
Aprea Therapeutics Inc APRE
Common Stock
2025-06-05 Grant 1,045 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com